The global Therapeutic Drug Monitoring (TDM) Service market size was valued at US$ 1989 million in 2024 and is forecast to a readjusted size of USD 2495 million by 2031 with a CAGR of 3.3% during review period.
Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs.
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient"s bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Therapeutic Drug Monitoring (TDM) Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Therapeutic Drug Monitoring (TDM) Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global Therapeutic Drug Monitoring (TDM) Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Therapeutic Drug Monitoring (TDM) Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Therapeutic Drug Monitoring (TDM) Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Therapeutic Drug Monitoring (TDM) Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Therapeutic Drug Monitoring (TDM) Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, bioMerieux, B眉hlmann Laboratories, Randox Laboratories, Sekisui Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Therapeutic Drug Monitoring (TDM) Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Blood Test
Urine Test
Saliva Test
麻豆原创 segment by Application
Hospital Labs
Independent Clinical Laboratories
Others
麻豆原创 segment by players, this report covers
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthineers
Bio-Rad Laboratories
bioMerieux
B眉hlmann Laboratories
Randox Laboratories
Sekisui Medical
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Therapeutic Drug Monitoring (TDM) Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Drug Monitoring (TDM) Service, with revenue, gross margin, and global market share of Therapeutic Drug Monitoring (TDM) Service from 2020 to 2025.
Chapter 3, the Therapeutic Drug Monitoring (TDM) Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Therapeutic Drug Monitoring (TDM) Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Drug Monitoring (TDM) Service.
Chapter 13, to describe Therapeutic Drug Monitoring (TDM) Service research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Therapeutic Drug Monitoring (TDM) Service by Type
1.3.1 Overview: Global Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Therapeutic Drug Monitoring (TDM) Service Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Blood Test
1.3.4 Urine Test
1.3.5 Saliva Test
1.4 Global Therapeutic Drug Monitoring (TDM) Service 麻豆原创 by Application
1.4.1 Overview: Global Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital Labs
1.4.3 Independent Clinical Laboratories
1.4.4 Others
1.5 Global Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size & Forecast
1.6 Global Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast by Region
1.6.1 Global Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Therapeutic Drug Monitoring (TDM) Service Product and Solutions
2.1.4 Roche Therapeutic Drug Monitoring (TDM) Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Roche Recent Developments and Future Plans
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business
2.2.3 Danaher Therapeutic Drug Monitoring (TDM) Service Product and Solutions
2.2.4 Danaher Therapeutic Drug Monitoring (TDM) Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Danaher Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Therapeutic Drug Monitoring (TDM) Service Product and Solutions
2.3.4 Abbott Therapeutic Drug Monitoring (TDM) Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring (TDM) Service Product and Solutions
2.4.4 Thermo Fisher Scientific Therapeutic Drug Monitoring (TDM) Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Siemens Healthineers
2.5.1 Siemens Healthineers Details
2.5.2 Siemens Healthineers Major Business
2.5.3 Siemens Healthineers Therapeutic Drug Monitoring (TDM) Service Product and Solutions
2.5.4 Siemens Healthineers Therapeutic Drug Monitoring (TDM) Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Siemens Healthineers Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring (TDM) Service Product and Solutions
2.6.4 Bio-Rad Laboratories Therapeutic Drug Monitoring (TDM) Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 bioMerieux
2.7.1 bioMerieux Details
2.7.2 bioMerieux Major Business
2.7.3 bioMerieux Therapeutic Drug Monitoring (TDM) Service Product and Solutions
2.7.4 bioMerieux Therapeutic Drug Monitoring (TDM) Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 bioMerieux Recent Developments and Future Plans
2.8 B眉hlmann Laboratories
2.8.1 B眉hlmann Laboratories Details
2.8.2 B眉hlmann Laboratories Major Business
2.8.3 B眉hlmann Laboratories Therapeutic Drug Monitoring (TDM) Service Product and Solutions
2.8.4 B眉hlmann Laboratories Therapeutic Drug Monitoring (TDM) Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 B眉hlmann Laboratories Recent Developments and Future Plans
2.9 Randox Laboratories
2.9.1 Randox Laboratories Details
2.9.2 Randox Laboratories Major Business
2.9.3 Randox Laboratories Therapeutic Drug Monitoring (TDM) Service Product and Solutions
2.9.4 Randox Laboratories Therapeutic Drug Monitoring (TDM) Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Randox Laboratories Recent Developments and Future Plans
2.10 Sekisui Medical
2.10.1 Sekisui Medical Details
2.10.2 Sekisui Medical Major Business
2.10.3 Sekisui Medical Therapeutic Drug Monitoring (TDM) Service Product and Solutions
2.10.4 Sekisui Medical Therapeutic Drug Monitoring (TDM) Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Sekisui Medical Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Therapeutic Drug Monitoring (TDM) Service Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Therapeutic Drug Monitoring (TDM) Service by Company Revenue
3.2.2 Top 3 Therapeutic Drug Monitoring (TDM) Service Players 麻豆原创 Share in 2024
3.2.3 Top 6 Therapeutic Drug Monitoring (TDM) Service Players 麻豆原创 Share in 2024
3.3 Therapeutic Drug Monitoring (TDM) Service 麻豆原创: Overall Company Footprint Analysis
3.3.1 Therapeutic Drug Monitoring (TDM) Service 麻豆原创: Region Footprint
3.3.2 Therapeutic Drug Monitoring (TDM) Service 麻豆原创: Company Product Type Footprint
3.3.3 Therapeutic Drug Monitoring (TDM) Service 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Therapeutic Drug Monitoring (TDM) Service Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Therapeutic Drug Monitoring (TDM) Service Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Therapeutic Drug Monitoring (TDM) Service Consumption Value by Type (2020-2031)
6.2 North America Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size by Application (2020-2031)
6.3 North America Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size by Country
6.3.1 North America Therapeutic Drug Monitoring (TDM) Service Consumption Value by Country (2020-2031)
6.3.2 United States Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Therapeutic Drug Monitoring (TDM) Service Consumption Value by Type (2020-2031)
7.2 Europe Therapeutic Drug Monitoring (TDM) Service Consumption Value by Application (2020-2031)
7.3 Europe Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size by Country
7.3.1 Europe Therapeutic Drug Monitoring (TDM) Service Consumption Value by Country (2020-2031)
7.3.2 Germany Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size by Region
8.3.1 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Consumption Value by Region (2020-2031)
8.3.2 China Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Therapeutic Drug Monitoring (TDM) Service Consumption Value by Type (2020-2031)
9.2 South America Therapeutic Drug Monitoring (TDM) Service Consumption Value by Application (2020-2031)
9.3 South America Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size by Country
9.3.1 South America Therapeutic Drug Monitoring (TDM) Service Consumption Value by Country (2020-2031)
9.3.2 Brazil Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size by Country
10.3.1 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Consumption Value by Country (2020-2031)
10.3.2 Turkey Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Drivers
11.2 Therapeutic Drug Monitoring (TDM) Service 麻豆原创 Restraints
11.3 Therapeutic Drug Monitoring (TDM) Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Therapeutic Drug Monitoring (TDM) Service Industry Chain
12.2 Therapeutic Drug Monitoring (TDM) Service Upstream Analysis
12.3 Therapeutic Drug Monitoring (TDM) Service Midstream Analysis
12.4 Therapeutic Drug Monitoring (TDM) Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthineers
Bio-Rad Laboratories
bioMerieux
B眉hlmann Laboratories
Randox Laboratories
Sekisui Medical
听
听
*If Applicable.
